• 

  Ranbaxy recalls generic Lipitor in U.S.

  March 09, 2014 19:48 IST

  New Delhi: Ranbaxy Laboratories, facing a host of regulatory issues, has recalled two batches of the company's generic version of Pfizer's cholesterol-lowering medicine Lipitor after a dose mix-up was detected. The company recalled the tablets

• 

  Singh brothers count on disclosure to counter Daiichi claims

  November 18, 2013 11:25 IST

  New Delhi: Facing arbitration claims by Daiichi Sankyo, Ranbaxy's former Indian promoters - Malvinder Mohan Singh, his brother Shivinder Mohan Singh and family - are counting on certain clauses in the share purchase agreement (SPA)

• 

  Nifty recovers early losses; remains above 5,900 mark

  October 07, 2013 20:49 IST

  Mumbai: The benchmark CNX Nifty of the National Stock Exchange (NSE) erased early losses and closed almost flat for the second straight trading session today on tail-end buying that helped it to hold on to

• 

  No plans to reduce workforce: Ranbaxy

  October 02, 2013 23:55 IST

  New Delhi: Pharmaceuticals major Ranbaxy Laboratories on Wednesday said it has no plans to reduce its workforce and is focusing on improving performance and productivity.“Ranbaxy has no plans to reduce its workforce either in the

• 

  Ranbaxy taking 'stringent steps' to end US FDA ban

  September 22, 2013 16:38 IST

  New Delhi: India's biggest drugmaker by sales, Ranbaxy Laboratories, has assured shareholders it is taking "stringent steps" to resolve a US ban on imports of medicines made at its newly renovated showcase plant.The US Food

• 

  Ranbaxy shares tank 35% on USFDA import alert buzz

  September 16, 2013 17:36 IST

  Mumbai: Shares of Ranbaxy Laboratories on Monday tanked by 35%, wiping-off Rs 5,159 crore from its market value, amid media reports that the US Food and Drug Administration ( USFDA) has issued an import alert

• 

  Ranbaxy shares jump on April-June U.S. sales

  August 08, 2013 11:51 IST

  New Delhi, Aug 8: Ranbaxy Laboratories Ltd shares gain 8.42 percent after better-than-expected April-June sales at its U.S. unit.The U.S. results were a relief after Ranbaxy shares had tumbled 36 percent as of Wednesday's close

• 

  UCB files cases against Ranbaxy, Aurobindo, Glenmark, Sun Pharma, others on patent issue

  July 22, 2013 18:06 IST

  Hyderabad, July 22: UCB, a global biopharma company, alongwith others has filed separate cases against as many as 15 drug makers, including India's Ranbaxy, Aurobindo, Zydus, Sun Pharma, Glenmark and Alembic Pharmaceuticals for allegedly infringing

• 

  Idaho gets $420,000 from Ranbaxy as part of settlement

  July 09, 2013 17:37 IST

  New Delhi, July 9: The US state of Idaho has said it has received almost $420,000 from drug major Ranbaxy as part of a $500 million settlement that the Indian firm had signed with US

• 

  Ranbaxy to sack 400 employees: Report

  July 06, 2013 11:12 IST

  New Delhi, July 6: In a major retrenchment drive, Gurgaon-headquartered Ranbaxy is planning to sack at least 400 executives at senior and middle management levels at global level."On Thursday, some senior executives from the finance

• 

  Supreme Court dismisses PIL against Ranbaxy on lack of evidence

  June 25, 2013 15:03 IST

  New Delhi, June 25: The Supreme Court has dismissed a PIL seeking a probe against Ranbaxy Laboratories Ltd for allegedly manufacturing and selling substandard medicines due to lack of evidence against the company.A bench of

Advertisement
• 

  Ranbaxy, Daiichi to leverage on brand strength for global markets

  June 23, 2013 15:26 IST

  New Delhi, June 23: In a bid to strengthen their hybrid business model, drug major Ranbaxy Laboratories and its parent firm Daiichi Sankyo will project only one of them as the face of the group

• 

  Ranbaxy issue a wake up call for Indian pharma firms: Kiran Mazumdar-Shaw

  June 09, 2013 14:16 IST

  New Delhi, June 9: The $500 million fine on Ranbaxy by US authorities after it pleaded guilty to “felony charges” for violating drug manufacturing norms is “a wake up call” for Indian pharmaceutical industry, according

• 

  Ranbaxy pleads guilty in US, to pay $500 million in settlement

  May 14, 2013 10:02 IST

  New Delhi, May 14: Pleading guilty to "felony charges" relating to manufacture and distribution of certain adulterated drugs made at two India units, the US subsidiary of Ranbaxy today agreed to pay $500 million —

• 

  Ranbaxy Q1 net profit plunges 90% to Rs 126 crore

  May 08, 2013 14:30 IST

  New Delhi, May 8: Ranbaxy Laboratories, India's largest drugmaker by sales, posted a 90 per cent drop in first quarter net profit compared to the same year-ago period.Ranbaxy's consolidated net profit fell to Rs 126

• 

  Ranbaxy Q3 consolidated net up at Rs 754 cr on forex gains

  November 08, 2012 19:02 IST

  New Delhi, Nov 8: Ranbaxy Laboratories Ltd, India's top drugmaker by sales, beat estimates with a 7.5 billion rupee ($140 million) quarterly net profit on stronger demand for its generic drugs in its key North

• 

  US Govt Seeks Permanent Injunction Against Ranbaxy

  January 26, 2012 13:49 IST

  Washington, Jan 26: In an unprecedented move, the US Justice Department has sought a permanent injunction against Ranbaxy, a move that will require the Indian pharmaceutical major to make fundamental changes to its plants both